Results 31 to 40 of about 72,557 (166)

The nanomedicine landscape of South Africa

open access: yesNanotechnology Reviews, 2017
Nanomedicine is one of the most exciting applications of nanotechnology and promises to address several of mankind’s healthcare needs. South Africa is one of the countries engaged in nanomedicine research and product development on the African continent.
Dube Admire, Ebrahim Naushaad
doaj   +1 more source

Endocytosis of nanomedicines

open access: yesJournal of Controlled Release, 2010
Novel nanomaterials are being developed to improve diagnosis and therapy of diseases through effective delivery of drugs, biopharmaceutical molecules and imaging agents to target cells in disease sites. Such diagnostic and therapeutic nanomaterials, also termed “nanomedicines”, often require site-specific cellular entry to deliver their payload to sub ...
Kabanov, Alexander V.   +2 more
openaire   +3 more sources

Polymer nanomedicines

open access: yesAdvanced Drug Delivery Reviews, 2020
Polymer nanomedicines (macromolecular therapeutics, polymer-drug conjugates, drug-free macromolecular therapeutics) are a group of biologically active compounds that are characterized by their large molecular weight. This review focuses on bioconjugates of water-soluble macromolecules with low molecular weight drugs and selected proteins.
Jindřich, Kopeček, Jiyuan, Yang
openaire   +3 more sources

Urea supplementation improves mRNA in vitro transcription by decreasing both shorter and longer RNA byproducts

open access: yesRNA Biology
The current letter to the editor describes the presence of RNA byproducts in small-scale in vitro transcription (IVT) reactions as evaluated by capillary gel electrophoresis, asymmetric flow field flow fractionation, immunoblotting, cell-free translation
Combes Francis   +6 more
doaj   +1 more source

Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine

open access: yesBioactive Materials, 2021
Nanomedicine involves the use of engineered nanoscale materials in an extensive range of diagnostic and therapeutic applications and can be applied to the treatment of many diseases.
Xi Chen   +3 more
doaj   +1 more source

Nanomedicine in Chemoradiation [PDF]

open access: yesTherapeutic Delivery, 2013
Chemoradiotherapy, the concurrent administration of chemotherapy and radiotherapy, is a treatment paradigm in oncology. It is part of the standard of care and curative treatment of many cancers. Given its importance, one of the primary goals of cancer research has been to identify agents and/or strategies that can improve the therapeutic index of ...
Seth M, Miller, Andrew Z, Wang
openaire   +2 more sources

Supramolecular nanostructure mimics GDNF trophic effects in vitro on human dopaminergic neurons

open access: yesnpj Regenerative Medicine
Peptide-based supramolecular nanostructures offer a versatile platform with substantial promise for clinical translation in regenerative medicine.
Oscar A. Carballo-Molina   +12 more
doaj   +1 more source

Discovery of MBL-AB01: a novel antibacterial xanthone antibiotic with high activity against methicillin-resistant Staphylococcus aureus

open access: yesApplied and Environmental Microbiology
A novel compound denoted MBL-AB01 was isolated from a marine Actinoalloteichus, which belongs to a rare and underexplored class of Actinobacteria. This work demonstrates that the novel compound MBL-AB01 shows very high activity in vitro against six ...
Kristin Fløgstad Degnes   +14 more
doaj   +1 more source

AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells

open access: yesDrug Delivery, 2018
Development of RNA interference-based therapies with appropriate therapeutic window remains a challenge for advanced cancers. Because cancer stem cells (CSC) are responsible of sustaining the metastatic spread of the disease to distal organs and the ...
Diana Rafael   +12 more
doaj   +1 more source

Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout

open access: yesBMC Pharmacology and Toxicology, 2022
Background Allopurinol (ALP), a xanthine oxidase inhibitor, is a first line drug for the treatment of gout and hyperuricemia. Being the member of BCS class II drugs, ALP has solubility problem, which affects its bioavailability.
Zakir Ali   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy